The biocompatible, osteoconductive and resorbable polymer Polyactive(TM) (PA) was investigated for its performance as a bone-graft substitute. The model consisted of a 4 mm borehole, 1.5 cm distal of the major trochanter in both femurs of a rabbit, of which one was filled with a cylinder of porous PA. The other was left untreated. PA70/30 and PA60/40 were investigated, both before and after being incubated with allogenic bone marrow. Analyses were performed after 4, 8, 26 and 52 weeks and comprised dual energy X-ray absorptiometry (DXA) and image analysis of histological sections. DXA revealed an increased bone mineral density in the filled defects compared to the controls, both at the defect and immediately proximal and distal of the defec...
The biocompatibility and potential osteoconductive properties of medium-chain-length polyhydroxyalka...
International audienceA new injectable and self-crosslinkable bone substitute (IBS2) was developed f...
International audienceA new injectable and self-crosslinkable bone substitute (IBS2) was developed f...
The biocompatible, osteoconductive and resorbable polymer Polyactive(TM) (PA) was investigated for i...
The biocompatible, osteoconductive and resorbable polymer Polyactive(TM) (PA) was investigated for i...
The quantity of bone formed in cylinders of a newly developed erodible copolymer, Polyactive(TM) (PA...
The quantity of bone formed in cylinders of a newly developed erodible copolymer, Polyactive(TM) (PA...
The quantity of bone formed in cylinders of a newly developed erodible copolymer, Polyactive(TM) (PA...
Purpose: This study aimed to micro radiographically evaluate the healing of grafted defects using a ...
Purpose: This study aimed to micro radiographically evaluate the healing of grafted defects using a ...
Objective: Moldable in situ self-stabilizing and hardening bone graft materials facilitate handling ...
OBJECTIVE: Moldable in situ self-stabilizing and hardening bone graft materials facilitate handling ...
Objectives. An assessment was done of the bone-healing rate after implantation of a polylactide/poly...
Objectives. An assessment was done of the bone-healing rate after implantation of a polylactide/poly...
International audienceA new injectable and self-crosslinkable bone substitute (IBS2) was developed f...
The biocompatibility and potential osteoconductive properties of medium-chain-length polyhydroxyalka...
International audienceA new injectable and self-crosslinkable bone substitute (IBS2) was developed f...
International audienceA new injectable and self-crosslinkable bone substitute (IBS2) was developed f...
The biocompatible, osteoconductive and resorbable polymer Polyactive(TM) (PA) was investigated for i...
The biocompatible, osteoconductive and resorbable polymer Polyactive(TM) (PA) was investigated for i...
The quantity of bone formed in cylinders of a newly developed erodible copolymer, Polyactive(TM) (PA...
The quantity of bone formed in cylinders of a newly developed erodible copolymer, Polyactive(TM) (PA...
The quantity of bone formed in cylinders of a newly developed erodible copolymer, Polyactive(TM) (PA...
Purpose: This study aimed to micro radiographically evaluate the healing of grafted defects using a ...
Purpose: This study aimed to micro radiographically evaluate the healing of grafted defects using a ...
Objective: Moldable in situ self-stabilizing and hardening bone graft materials facilitate handling ...
OBJECTIVE: Moldable in situ self-stabilizing and hardening bone graft materials facilitate handling ...
Objectives. An assessment was done of the bone-healing rate after implantation of a polylactide/poly...
Objectives. An assessment was done of the bone-healing rate after implantation of a polylactide/poly...
International audienceA new injectable and self-crosslinkable bone substitute (IBS2) was developed f...
The biocompatibility and potential osteoconductive properties of medium-chain-length polyhydroxyalka...
International audienceA new injectable and self-crosslinkable bone substitute (IBS2) was developed f...
International audienceA new injectable and self-crosslinkable bone substitute (IBS2) was developed f...